CLINICAL_TRIALS trial_result · 2016-09-07

Clinical Trial Update: An Investigational Drug Co-Administered With Insulin in Patients With Type 2 Diabetes (0478-065) [Phase 3]

A Phase 3 trial investigating an investigational drug co-administered with insulin in Type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED